Threatened Abortion Clinical Trial
— POTAOfficial title:
Pregnancy Outcome in Woman With Threatened Abortion
Verified date | February 2016 |
Source | Bnai Zion Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | Israel: Ministry of Health |
Study type | Observational |
The study aims to quantify the relations between first & second trimester bleeding and maternal & neonatal morbidity. Additionally, the study will help in assessing the risk for abortions in women with threatened abortions and the risk factors for threatened abortion.
Status | Completed |
Enrollment | 3000 |
Est. completion date | January 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Women who attended the Emergency department with vaginal bleeding and/or abdominal pain and were on their 20th week of pregnancy or less. Exclusion Criteria: - Women with any background that can explain vaginal bleeding or any other circumstance that can explain it. |
Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Bnai Zion Medical Center |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Maternal and neonatal outcome in pregnancies with 1st and 2nd trimester bleeding | by using our data in the past 7 years we will examine retrospectively cases of patients from their first admission due to vaginal bleeding throgh their pregnancy and labor . the mesearment will include : Intra uterine growth retardation , Antepartum hemorrhage, premature rupture of membrane, Intra uterine fetal death , Preterm delivery, Apgar less than 7, Congenital malformation, Mode of delivery - vaginal delivery vs. cesarean section |
9 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02420769 -
Corpus Luteum and Uterine Artery Doppler With Serum P and CA125 in Threatened Abortion
|
N/A | |
Withdrawn |
NCT01501890 -
Progesterone for First Trimester Vaginal Bleeding
|
N/A | |
Completed |
NCT03930212 -
Progesterone Supplementation in Threatened Abortion
|
Phase 4 | |
Completed |
NCT04788108 -
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion
|
Phase 4 |